Company: BLLN
Filing Date: 2025-06-20
Form Type: DRS
Source: 0000950123-25-006095
Chunk: 82

Company: BillionToOne, Inc.
Filing Date: 2025-06-20
Form: DRS
Chunk 82
---
 payment may be made under federal health care programs, such as Medicare, unless a safe harbor applies;                                                                                        |

| • |     | the federal Eliminating Kickbacks in Recovery Act (EKRA), which prohibits knowingly and willfully soliciting or receiving                                                                                                                         
 any remuneration (including any kickback, bribe or rebate) directly or indirectly, overtly or covertly, in cash or in kind, in return for referring a patient or patronage to a laboratory; or paying or offering any remuneration (including any 
 kickback, bribe or rebate) directly or indirectly, overtly or covertly,                                                                                                                                                                           |

56

| in cash or in kind, to induce a referral of an individual to a laboratory or in exchange for an individual using the services of that laboratory billed to either commercial payors or government 
 payors;                                                                                                                                                                                           |

| • |     | the Stark Law and similar state laws, which prohibits a physician from making a referral for certain designated health                                                                                                                                   
 services covered by the Medicare or Medicaid program, including laboratory and pathology services, if the physician or an immediate family member of the physician has a financial relationship with the entity providing the designated health services 
 and prohibits that entity from billing, presenting or causing to be presented a claim for the designated health services furnished pursuant to the prohibited referral, unless an exception applies;                                                     |

| • |     | the federal Civil Monetary Penalties Law, which prohibits, among other things, the offering or transfer of remuneration to                                                                                                                     
 a Medicare or state healthcare program beneficiary if the person knows or should know it is likely to influence the beneficiary’s selection of a particular provider, practitioner or supplier of services reimbursable by Medicare or a state 
 healthcare program, unless an exception applies;                                                                                                                                                                                               |

| • |     | federal and state “Anti-Markup” rules, which, among other things, typically prohibit a physician or supplier                                                                                                                       
 billing for molecular diagnostic tests (with certain exceptions) from marking up the price of a purchased test performed by another physician or supplier that does not “share a practice” with the billing physician or supplier; |

| • |     | the federal government may bring a lawsuit under the False Claims Act (FCA), against any party whom it believes has                                                                                                                                       
 knowingly or recklessly presented, or caused to be presented, a false or fraudulent request for payment from the federal government, or who has made a false statement or used a false record to get a claim for payment approved. The federal government